These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4818170

  • 1. Letter: Amphotericin pharmacophobia and renal toxicity.
    Forgan-Smith R, Darrell JH.
    Br Med J; 1974 Feb 09; 1(5901):244. PubMed ID: 4818170
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lipid-based formulations of amphotericin B.
    Plotnick AN.
    J Am Vet Med Assoc; 2000 Mar 15; 216(6):838-41. PubMed ID: 22570893
    [No Abstract] [Full Text] [Related]

  • 4. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function.
    Burgess JL, Birchall R.
    Am J Med; 1972 Jul 15; 53(1):77-84. PubMed ID: 4667504
    [No Abstract] [Full Text] [Related]

  • 5. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function.
    Burges JL, Birchall R.
    Am J Med; 1972 Jul 15; 53(1):77-84. PubMed ID: 5037291
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lack of nephrotoxicity with the administration of amphotericin B in a lipid emulsion.
    Smith TM, Strozyk WR.
    Ann Pharmacother; 1994 Nov 15; 28(11):1307-8. PubMed ID: 7849357
    [No Abstract] [Full Text] [Related]

  • 8. Is liposomal amphotericin B really safety in neonates?
    Karadag-Oncel E, Ozsurekci Y, Yurdakok M, Kara A.
    Early Hum Dev; 2013 Jan 15; 89(1):35-6. PubMed ID: 22877627
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amphotericin B: a second look.
    Medoff G, Kobayashi GS.
    Compr Ther; 1977 Jul 15; 3(7):20-4. PubMed ID: 880788
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.
    Branch RA.
    Arch Intern Med; 1988 Nov 15; 148(11):2389-94. PubMed ID: 3056312
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Amphotericin B--specifics of administration.
    Goodman JS, Koenig MG.
    Mod Treat; 1970 May 15; 7(3):581-95. PubMed ID: 4920806
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes.
    Garbino J, Markham L, Matulionyte R, Rives V, Lew D.
    Scand J Infect Dis; 2006 May 15; 38(2):110-3. PubMed ID: 16449001
    [Abstract] [Full Text] [Related]

  • 20. Current and future chemotherapy of central nervous system fungal infections.
    Utz JP.
    Adv Neurol; 1974 May 15; 6():127-32. PubMed ID: 4480013
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.